Form D · Pharmaceuticals
Reven Holdings Inc
Golden, CO · CIK 0001751949
Offering snapshot reported Sep 18, 2018 · SEC filing
- Reported sold
- $200K Offering amount: $350M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Sep 3, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 18, 2018 | Initial | $200,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b, 4a5
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $5M (estimated)
- Finders' fees
- $5M (estimated)
- Form D file number
- 021-321640
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| NA | None |
Source: Form D, filed Sep 18, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian David Denomme | Director, Executive |
| Michael Kevin Handley | Director, Executive |
| Peter Lange | Director, Executive |
| Michael Allen Volk | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
600 Corporate Drive Suite D
Golden, CO, 34208
Golden, CO, 34208